Literature DB >> 24256958

Osmotic demyelination syndrome (central pontine and extrapontine myelinolysis with coagulative necrosis of the putamina and cortical laminar necrosis). A case report and review of the literature.

A Burgetova1, M Vaneckova, Z Seidl, O Dolezal.   

Abstract

Central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) are disorders frequently associated with serum osmotic imbalance. The prognosis is very variable from complete regression of clinical symptomatology to signs of significant quadruparesis, a vegetative state and death. We report the case of a 25-year-old man with a diagnosis of osmotic demyelination syndrome. The patient was young healthy man with no history of chronic alcoholism or malnutrition. He underwent head trauma associated with consumption of alcohol, being diagnosed with cerebral commotion. Four days later he presented with generalised epileptic convulsions with unconsciousness. Laboratory findings showed significant hyponatremia and hypochlorinemia. Following the rapid correction of osmotic conditions of serum, spastic quadruparesis and coma developed. MRI of the brain showed finding of CPM and EPM, cortical laminar necrosis (CLN) and coagulative necrosis in the putamina. Our case is suggestive in the rare MRI appearance of myelinolysis in addition to CLN and coagulative necrosis in the basal ganglia following the rapid correction of serum osmolarity. We suggest that this finding is prognostically very unfavourable. In the reported patient clinically initial neurological deficit progressed to a vegetative state within one month.

Entities:  

Year:  2008        PMID: 24256958     DOI: 10.1177/197140090802100409

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  1 in total

1.  Cortical laminar necrosis following the rapid correction of drug-induced hyponatremia.

Authors:  Xiaohui Liu; Xinya Zhao; Jiangfei Yang; Xiaojuan Han; Xiyun Ruan; Yifeng Du
Journal:  Neurol Sci       Date:  2015-05-19       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.